ScienceDex / Researcher record
Abate-Daga, Daniel
- Moffitt Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $501,190 | 1 | #21,673 |
| 2022 | $489,115 | 1 | #23,499 |
| 2023 | $659,784 | 2 | #17,749 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20211 record
- FY20221 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing Abate-Daga, Daniel as a PI. Multi-PI records show the full award amount for context.
- 5R01CA241169-04R01Contact PIUnderstanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.$462.9Kaward amount
- 1R21CA280233-01R21Contact PIKIR2DL2 Immune Checkpoint as Modulator of T-Cell Effector Function$196.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Abate-Daga, Daniel as a PI.
FY2023 award administered by Moffitt Cancer Center (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardMoffitt Cancer Center
- 2021$500K Cumulative Funding
- 2022R01 Grant Holder
- 2023$1M Cumulative Funding